MAPT and Alzheimer disease: Although a lower distribution of Tau inclusions throughout the brain is observed in DM patients compared with other pathologies, such as AD, the topographic distribution and expression of NFTs are still higher than that in unaffected individuals of the same age (Vermersch et al., 1996).